Novel Analysis Confirms Pivotal Stroke Trial Results Favoring TPA Use

KISSIMMEE, FLA. — A reanalysis of data from a pivotal stroke trial confirms a robust beneficial treatment effect of intravenous tissue plasminogen activator, Dr. Jeffrey L. Saver reported at the 31st International Stroke Conference.